Top Five Intraday Stocks to Watch 3rd Nov 2025: Breakout Momentum & Short-Term Trading Opportunities
By CapitalKeeper | Top Intraday Stock | Smart Trading Starts Here
Discover the top five intraday stocks showing strong breakout patterns Ashoka Buildcon, Latent View, Supriya Lifescience, Strides Pharma, and Sumitomo Chemicals. Technical insights, support levels, and momentum outlooks for smart short-term traders.
🔥 Top Five Intraday Stocks for Short-Term Momentum – November 2025 Edition
As markets gear up for the year-end momentum phase, traders are seeing a refreshing shift toward breakout opportunities across mid-cap and sector-specific names. Volatility remains a trader’s best friend, and the recent price action signals a renewed appetite for short-term tactical trades.
In today’s CapitalKeeper “Top Five Intraday Stocks” list, we focus on stocks that are showing clear technical breakouts, rising volume, and validated support zones a perfect blend for intraday and positional setups.
1️⃣ Ashoka Buildcon (ASHOKA) – CMP ₹205
Technical Structure: Resistance Breakout | High Volume Confirmation
Ashoka Buildcon has been quietly consolidating between the ₹180–₹205 band for several weeks. This week, the stock closed above its trendline resistance, marking a significant higher-high structure on the daily chart.
🔍 Key Observations:
- Strong bullish candle with expanding volumes signals institutional buying.
- Short-term moving averages (20 EMA & 50 EMA) show an emerging crossover, confirming momentum alignment.
- RSI comfortably above 60, indicating sustained strength.
📈 Trading Setup:
- Buy Zone: ₹202–₹206
- Target Range: ₹220–₹235
- Support Area: ₹180–₹185
- Stop-Loss: Below ₹178
Viewpoint:
Ashoka Buildcon is among the best-placed infra names technically, and with government focus on capital expenditure and highway projects, a medium-term rally could be developing. The stock’s pattern mirrors earlier pre-breakout stages seen in PNC Infra and NCC during 2023–24.
2️⃣ Latent View Analytics (LATENTVIEW) – CMP ₹448
Technical Structure: Trendline Breakout | Reversal from Support
After weeks of consolidation around ₹410–₹420, Latent View has reversed sharply from its support zone and is now trading above the descending trendline resistance.
🔍 Key Observations:
- Strong recovery from its short-term base, indicating renewed interest from midcap growth investors.
- RSI divergence on the daily chart turned positive after two months.
- Weekly closing above ₹445 confirms technical breakout strength.
📈 Trading Setup:
- Buy Zone: ₹445–₹450
- Target Range: ₹470–₹495
- Stop-Loss: ₹430
Viewpoint:
Latent View is a data analytics and AI-backed IT firm that remains well-positioned to ride India’s digital transformation story. The breakout aligns with the sector’s broader recovery led by names like Persistent and Tata Elxsi.
A move toward ₹500 looks plausible as the stock regains its pre-correction momentum.
3️⃣ Supriya Lifescience (SUPRIYA) – CMP ₹776
Technical Structure: Weekly Trendline Breakout | High Volume Confirmation
Supriya Lifescience has finally given a clean breakout on the weekly timeframe, confirming a change of structure from sideways to bullish. The stock’s volume expansion and strong close indicate that the market is ready for a larger move.
🔍 Key Observations:
- Consistent delivery volumes over the past 10 sessions hint at positional accumulation.
- The stock has broken a six-month consolidation range with a solid candle.
- Momentum indicators such as MACD and RSI confirm trend alignment.
📈 Trading Setup:
- Buy Zone: ₹770–₹785
- Target Range: ₹1,050–₹1,200
- Support Zone: ₹700–₹710
- Stop-Loss: Below ₹695
Viewpoint:
With strong fundamentals, increasing export demand, and improving margins, Supriya Lifescience looks set for a re-rating in the short to medium term. The breakout resembles setups seen in pharma midcaps like Laurus Labs and Aarti Drugs before their last rallies.
Expect a gradual upward grind toward ₹1,000+ as long as the broader pharma index holds strength.
4️⃣ Strides Pharma (STAR) – CMP ₹934
Technical Structure: Trendline Breakout After Retest | Renewed Upside
Strides Pharma has completed a textbook breakout-retest pattern, bouncing back strongly after retesting its breakout level around ₹910–₹915. This confirms the stock’s structural strength and readiness for the next leg higher.
🔍 Key Observations:
- Post-breakout retest gave a strong reversal candle supported by rising volumes.
- Pharma sector tailwinds continue with margin improvement and domestic demand uptick.
- RSI >65 and rising ADX suggest momentum expansion.
📈 Trading Setup:
- Buy Zone: ₹925–₹935
- Target Range: ₹970–₹1,020
- Stop-Loss: ₹910
Viewpoint:
Strides remains a core midcap pharma breakout play, aligning with sector strength. The stock’s price structure and accumulation zones mirror mid-2021 setups before its 20% rally. Traders can maintain a bullish bias while trailing stop-losses progressively.
5️⃣ Sumitomo Chemicals (SUMICHEM) – CMP ₹502
Technical Structure: Volume-Based Reversal | Gradual Accumulation
Sumitomo Chemicals India continues to show bottom formation signs after months of range-bound action. Smart money seems to be flowing in gradually, as evident from consistent delivery volume spikes.
🔍 Trading Plan (Positional + Staggered Buying):
- Add 40% near ₹495
- Add More Near ₹465
- Stop-Loss: Below ₹440
- Targets: ₹600 – ₹680
Viewpoint:
Sumichem’s long-term structure remains intact, with fundamental positives including clean balance sheet, strong agri demand recovery, and focus on export markets. The recent uptick in agrochemical stocks like PI Industries and UPL further supports sector sentiment.
This stock can offer both swing and positional gains in the coming months.
💡 Sectoral Insights: Why Breakouts Are Back
The broader Nifty Midcap and Smallcap indices have resumed upward trends after brief consolidation. Key triggers include:
- 🔹 Strong Q2 results from mid-sized companies showing margin expansion.
- 🔹 Renewed FII buying in select sectors like infra, pharma, and chemicals.
- 🔹 Improving liquidity and positive market breadth.
- 🔹 Rotation trade from overbought large-caps to under-owned midcaps.
This rotation often precedes multi-week rallies in breakout names — precisely the setups being observed in our top picks.
📊 Technical Summary Table
| Stock | CMP (₹) | Pattern Type | Target Range (₹) | Stop-Loss (₹) | View |
|---|---|---|---|---|---|
| Ashoka Buildcon | 205 | Resistance Breakout | 220–235 | 178 | Bullish |
| Latent View | 448 | Trendline Breakout | 470–495 | 430 | Bullish |
| Supriya Lifescience | 776 | Weekly Breakout | 1050–1200 | 695 | Strong Bullish |
| Strides Pharma | 934 | Retest Breakout | 970–1020 | 910 | Bullish |
| Sumitomo Chemical | 502 | Accumulation Breakout | 600–680 | 440 | Positional Bullish |
🎯 Final Takeaway
Market structure continues to favor breakout-based intraday and swing trades. The stocks listed above — Ashoka Buildcon, Latent View, Supriya Lifescience, Strides Pharma, and Sumitomo Chemical — are technically primed for the next leg higher, supported by sector rotation, volume confirmation, and clean price structures.
As always, traders are advised to:
- Maintain strict stop-loss discipline,
- Scale positions as per capital exposure, and
- Trail profits as targets approach.
In this phase of broad-based recovery, momentum trading with discipline can yield strong risk-adjusted returns.
📌 For daily trade setups, technical learning, and smart investing tips, stay tuned to CapitalKeeper.in
📌 For more real-time updates, trade setups, and investment insights — follow us on [Telegram] and [WhatsApp Channel] subscribe to our newsletter!
📌 Disclaimer
The content provided on CapitalKeeper.in is for informational and educational purposes only and does not constitute investment, trading, or financial advice. While we strive to present accurate and up-to-date market data and analysis, we make no warranties or representations regarding the completeness, reliability, or accuracy of the information.
Stock market investments are subject to market risks, and readers/investors are advised to conduct their own due diligence or consult a SEBI-registered financial advisor before making any investment decisions. CapitalKeeper and its authors are not liable for any loss or damage, direct or indirect, arising from the use of this information.
All views and opinions expressed are personal and do not reflect the official policy or position of any agency or organization. Past performance is not indicative of future results.
By using this website, you agree to the terms of this disclaimer.
Ranjit Sahoo
Founder & Chief Editor – CapitalKeeper.in
Ranjit Sahoo is the visionary behind CapitalKeeper.in, a leading platform for real-time market insights, technical analysis, and investment strategies. With a strong focus on Nifty, Bank Nifty, sector trends, and commodities, she delivers in-depth research that helps traders and investors make informed decisions.
Passionate about financial literacy, Ranjit blends technical precision with market storytelling, ensuring even complex concepts are accessible to readers of all levels. Her work covers pre-market analysis, intraday strategies, thematic investing, and long-term portfolio trends.
When he’s not decoding charts, Ranjit enjoys exploring coastal getaways and keeping an eye on emerging business themes.
📌 Follow Ranjit on:
LinkedIn | Twitter/X | Instagram | ✉️ contact@capitalkeeper.in